Skip to content
DataLookout
Menu

NCT05401630

Mental Stress Reactivity in Women With CMD

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 2 years 2 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 7 versions: 5 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion dates pushed to Dec 2028 Show 4 more changesShow less
    • Eligibility criteria expanded, about 92 words
    • Secondary endpoints: details revised at 3 of 3 entries
    • Study description revised
    • Site details revised at 1 of 4 sites
  2. Notable Eligibility criteria expanded, about 4 words
    • Secondary endpoints: details revised at 1 of 3 entries
    • Study description revised
    v6
  3. Notable Phase: Not specified to Not applicable
    • Primary completion date: Jun 2027 to Sep 30, 2026
    • Study completion date: Dec 2027 to Dec 31, 2026
    v3
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jun 2022 to Jul 19, 2022
    • Site details revised at 4 of 4 sites
    v2
  5. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Planar late Heart to Mediastinal Ratio (MIBG imaging)
Timeframe: At the end of MIBG procedure
Changes in HRV with mental stress
Timeframe: Baseline (prior to stress testing) and during mental stress test
Changes in pre-ejection period (PEP) with mental stress
Timeframe: Baseline (prior to stress testing) and during mental stress test

Secondary (3)

Changes in flow mediated dilation (FMD test) to acute mental stress in CMD women.
Changes in Peripheral arterial tonometry (PAT) test to acute mental stress in CMD women.
Examine whether chronic stress burden and autonomic dysfunction during daily life is elevated in CMD women.

Arms and interventions

Symptomatic women with no obstructive CAD who have CMDExperimental

Symptomatic women with chest pain and no obstructive CAD who have an abnormal myocardial flow reserve (MFR \< 2.5)

Symptomatic women with chronic obstructive CAD (oCAD)Experimental

This group will serve as one comparison group since these women represent the prevailing paradigm of ischemia from obstructive stenosis while sharing common cardiovascular risk factors with the CMD group.

Asymptomatic control women with no prior history of CAD or anginaActive comparator

Asymptomatic control women with no prior history of CAD or angina, who are age-matched to the CMD women; not on any cardiac medications, who will also have to pass a maximal Bruce protocol exercise treadmill test.

Other: Study Procedures

Sites

4 sites in 1 country